Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Bluegreen who wrote (8477)	1/25/1999 5:42:00 PM
From: aknahow	Respond to of 17367

Bluegreen, how many DSMB meetings were there in 1998? Did you read my post on Centoxin? Do you think that by agreeing to a total specific mortality that perhaps everyone was trying to speed things up? Even so I still agree with you about the FDA. The fact that the FDA is involved in efficacy, could be seen as another reason why some doctors are apathetic about keeping up with research. They might think why bother, if it's approved by the FDA I can use it without having to get too involved in the details. In any case, it is difficult for me to understand how FDA will stimulate the inept doctors to become better. Most of the examples mentioned by SL involved drugs already approved by the FDA and they were either not used or used inappropriately.

To: Bluegreen who wrote (8477)	1/25/1999 6:20:00 PM
From: Bluegreen	Read Replies (1) \| Respond to of 17367

SL wrote, >>>>>So biotech hums away at top speed, providing great potential benefit at low risk to humanity: scientists toil away at the lab bench, clincial investigators dutifully investigate, and companies skillfully move through the regulatory maze. FDA Approval. Then there is the real world where the biotech must convince a doctor to change their practice, according to the EVIDENCE of safety and efficacy.<<<< You can't be serious can you? Biotechs at top speed? Most have gone bankrupt and in case you haven't noticed most of the rest are shall we say, in dire need of money? Xoma at this very moment can't proceed with new indications for lack of funds. Now is that what you call humming away at top speed? I have invested in Xoma that has both misled me and pulled the old convertible pref. trick. Desperate acts wouldn't you say? SL, our founding fathers didn't want a big brother maze government. Our government is for prudent regulation, not a total domination monopolistic maze. It seems you say government maze like you like it, when you know the government should be honest, upfront and straightforward. I can tell you after Xoma, I will avoid most biotechs in the future. So should any serious investor until the FDA gets its much needed reform on efficacy matters. SL, once again we have the best healthcare in the world in spite of big brother based ideas of what is efficacy evidence. There you go, evidence based medicine equals FDA idea of efficacy which to me is old ugly big brother evidence based medicine. I can imagine your resistance to change when fast track was initiated. Oh yes, I know you think it is wonderful now and so too will you find the new reforms before Congress on efficacy. Just think a little about the proposed changes, they make sense and everyone will benefit just like we benefited from the CHANGE to fast track. And, man oh man was fast track opposed with the same vigor you are now exhibiting toward change in efficacy models.